SCYNEXIS Stock

SCYNEXIS ROA

The Return on Assets (ROA) of SCYNEXIS (SCYX) as of Jul 15, 2026 is -23.49 %. In the previous year, Return on Assets (ROA) was 52.21 % — a change of -144.98% (lower).

ROA

-23.49 %

YoY

-144.98%

Last updated:

In 2026, SCYNEXIS's return on assets (ROA) was -23.49 %, a -144.98% increase from the 52.21 % ROA in the previous year.

Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

ROA Details

Understanding SCYNEXIS's Return on Assets (ROA)

SCYNEXIS's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing SCYNEXIS's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider SCYNEXIS's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in SCYNEXIS’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about SCYNEXIS stock

Return on Assets (ROA) of SCYNEXIS is -23.49 % in 2026.

Access this data via the Eulerpool API

Profitability — SCYNEXIS

All Key Metrics — SCYNEXIS